Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
235 | 3771 | 33.2 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
200 | 20446 | PULMONARY EMBOLISM//VENOUS THROMBOEMBOLISM//DEEP VEIN THROMBOSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | THROMBOPROPHYLAXIS | Author keyword | 164 | 45% | 7% | 272 |
2 | VENOUS THROMBOEMBOLISM | Author keyword | 148 | 20% | 18% | 671 |
3 | DEEP VEIN THROMBOSIS | Author keyword | 72 | 17% | 10% | 377 |
4 | MEDICAL PATIENTS | Author keyword | 53 | 62% | 1% | 55 |
5 | DEEP VEIN THROMBOSIS PROPHYLAXIS | Author keyword | 34 | 93% | 0% | 13 |
6 | FONDAPARINUX | Author keyword | 32 | 28% | 3% | 96 |
7 | LOW MOLECULAR WEIGHT HEPARIN | Author keyword | 25 | 11% | 6% | 209 |
8 | DEEP VENOUS THROMBOSIS | Author keyword | 24 | 13% | 4% | 168 |
9 | PROLONGED PROPHYLAXIS | Author keyword | 21 | 90% | 0% | 9 |
10 | THROMBOSIS PROPHYLAXIS | Author keyword | 17 | 42% | 1% | 32 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THROMBOPROPHYLAXIS | 164 | 45% | 7% | 272 | Search THROMBOPROPHYLAXIS | Search THROMBOPROPHYLAXIS |
2 | VENOUS THROMBOEMBOLISM | 148 | 20% | 18% | 671 | Search VENOUS+THROMBOEMBOLISM | Search VENOUS+THROMBOEMBOLISM |
3 | DEEP VEIN THROMBOSIS | 72 | 17% | 10% | 377 | Search DEEP+VEIN+THROMBOSIS | Search DEEP+VEIN+THROMBOSIS |
4 | MEDICAL PATIENTS | 53 | 62% | 1% | 55 | Search MEDICAL+PATIENTS | Search MEDICAL+PATIENTS |
5 | DEEP VEIN THROMBOSIS PROPHYLAXIS | 34 | 93% | 0% | 13 | Search DEEP+VEIN+THROMBOSIS+PROPHYLAXIS | Search DEEP+VEIN+THROMBOSIS+PROPHYLAXIS |
6 | FONDAPARINUX | 32 | 28% | 3% | 96 | Search FONDAPARINUX | Search FONDAPARINUX |
7 | LOW MOLECULAR WEIGHT HEPARIN | 25 | 11% | 6% | 209 | Search LOW+MOLECULAR+WEIGHT+HEPARIN | Search LOW+MOLECULAR+WEIGHT+HEPARIN |
8 | DEEP VENOUS THROMBOSIS | 24 | 13% | 4% | 168 | Search DEEP+VENOUS+THROMBOSIS | Search DEEP+VENOUS+THROMBOSIS |
9 | PROLONGED PROPHYLAXIS | 21 | 90% | 0% | 9 | Search PROLONGED+PROPHYLAXIS | Search PROLONGED+PROPHYLAXIS |
10 | THROMBOSIS PROPHYLAXIS | 17 | 42% | 1% | 32 | Search THROMBOSIS+PROPHYLAXIS | Search THROMBOSIS+PROPHYLAXIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DEEP VEIN THROMBOSIS | 349 | 20% | 42% | 1600 |
2 | LOW DOSE HEPARIN | 229 | 50% | 9% | 329 |
3 | PROLONGED THROMBOPROPHYLAXIS | 199 | 85% | 3% | 104 |
4 | FATAL PULMONARY EMBOLISM | 169 | 61% | 5% | 180 |
5 | PULMONARY EMBOLISM | 144 | 15% | 23% | 873 |
6 | MOLECULAR WEIGHT HEPARIN | 118 | 13% | 23% | 866 |
7 | ENOXAPARIN | 117 | 23% | 12% | 439 |
8 | THROMBOPROPHYLAXIS | 115 | 32% | 8% | 302 |
9 | TOTAL HIP REPLACEMENT | 78 | 16% | 12% | 438 |
10 | POSTOPERATIVE FONDAPARINUX | 72 | 57% | 2% | 86 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Prevention of venous thromboembolism | 2008 | 1569 | 633 | 53% |
Heparin Thromboprophylaxis in Medical-Surgical Critically Ill Patients: A Systematic Review and Meta-Analysis of Randomized Trials | 2013 | 22 | 29 | 86% |
Venous Thromboembolism Prophylaxis in Hospitalized Medical Patients and Those With Stroke: A Background Review for an American College of Physicians Clinical Practice Guideline | 2011 | 61 | 64 | 75% |
Meta-analysis: Anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients | 2007 | 224 | 40 | 73% |
Prevention of venous thromboembolism | 2001 | 518 | 462 | 60% |
Aspirin for the Prophylaxis of Venous Thromboembolic Events in Orthopedic Surgery Patients: A Comparison of the AAOS and ACCP Guidelines with Review of the Evidence | 2013 | 12 | 33 | 73% |
Symptomatic In-Hospital Deep Vein Thrombosis and Pulmonary Embolism Following Hip and Knee Arthroplasty Among Patients Receiving Recommended Prophylaxis A Systematic Review | 2012 | 42 | 73 | 45% |
Prolonged thromboprophylaxis with Low Molecular Weight heparin for abdominal or pelvic surgery | 2009 | 51 | 21 | 86% |
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery | 2001 | 292 | 81 | 75% |
Prevention of Symptomatic Pulmonary Embolism in Patients Undergoing Total Hip or Knee Arthroplasty | 2009 | 52 | 39 | 77% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | THROMBOSIS THROMBOPHILIA | 6 | 80% | 0.1% | 4 |
2 | HAEMATOL COAGULAT UNIT | 4 | 75% | 0.1% | 3 |
3 | THROMBOEMBOLISM PROGRAM | 4 | 46% | 0.2% | 6 |
4 | CLIN THROMBOSIS | 4 | 30% | 0.3% | 10 |
5 | EXPT ONKOL THER IEFOR | 3 | 14% | 0.6% | 22 |
6 | VERKSAMHETSOMRADE AKUTSJUKVARD | 3 | 100% | 0.1% | 3 |
7 | OSTRA | 3 | 45% | 0.1% | 5 |
8 | EXP ONKOL THER IEFOR | 3 | 60% | 0.1% | 3 |
9 | JEFFERSON VASC DIS | 2 | 38% | 0.1% | 5 |
10 | ANESTHESIOL CRIT CARE SERV | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000267318 | VENOUS THROMBOEMBOLISM PROPHYLAXIS//BLUNT SOLID ORGAN INJURY//SEQUENTIAL COMPRESSION DEVICES |
2 | 0.0000143792 | RESIDUAL THROMBOSIS//RECURRENT VENOUS THROMBOEMBOLISM//ANTICOAGULANT RELATED BLEEDING |
3 | 0.0000124128 | LOW MOLECULAR WEIGHT HEPARIN//UNFRACTIONATED HEPARIN//ANTI XA ACTIVITY |
4 | 0.0000113953 | D DIMER//DISTAL DEEP VEIN THROMBOSIS//CALF VEIN THROMBOSIS |
5 | 0.0000111796 | RIVAROXABAN//DABIGATRAN//APIXABAN |
6 | 0.0000080731 | CANCER PROCOAGULANT//TISSUE FACTOR//CANCER ASSOCIATED THROMBOSIS |
7 | 0.0000069671 | EXTERNAL COUNTERPULSATION//ENHANCED EXTERNAL COUNTERPULSATION//ENHANCED EXTERNAL COUNTERPULSATION EECP |
8 | 0.0000064272 | PULMONARY EMBOLISM//EMBOLISM PULMONARY//PULMONARY ANGIOGRAPHY |
9 | 0.0000055065 | POST THROMBOTIC SYNDROME//MAY THURNER SYNDROME//POSTTHROMBOTIC SYNDROME |
10 | 0.0000049602 | COUMARIN EMBRYOPATHY//WARFARIN EMBRYOPATHY//MECHANICAL PROSTHETIC HEART VALVES |